The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Life Insurance Corporation of India (LIC) disclosed under SEBI SAST Regulation 29(1) that it acquired 2,02,500 equity shares (0.008%) of Sun Pharmaceutical Industries through market purchase on 13 January 2026. With this small purchase, LIC's holding in Sun Pharma rose from 4.996% (11,98,76,648 shares) to 5.004% (12,00,79,148 shares), crossing the key 5% disclosure threshold. LIC clarified it does not belong to the promoter or promoter group of the company. This is a routine creeping acquisition filing triggered by crossing the 5% mark.
The acquisition itself is tiny in size (0.008%) and is unlikely to move the stock price. However, LIC crossing the 5% mark signals a large institutional investor accumulating shares, which may be viewed positively by retail investors as a sign of institutional confidence. Watch for further disclosures if LIC moves toward the 10% threshold.